Status:
UNKNOWN
The Role of TCM on ERAS of Rectal Cancer Patients
Lead Sponsor:
Peking University Cancer Hospital & Institute
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This study is to investigate the role of traditional Chinese medicine (TCM) on the postoperative recovery of rectal cancer patients.
Detailed Description
The hypothesis is that TCM can decrease the postoperative complications for rectal cancer. So the study is to investigate the role of traditional Chinese medicine (TCM) on the postoperative recovery o...
Eligibility Criteria
Inclusion
- Signed written consent form;
- Age from 18 to 75 years old;
- Pathological diagnosis as rectal adenocarcinoma;
- undergo laparoscopic curative surgery;
- Patients' TCM syndrome accords with thoses of spleen deficiency syndrome;
Exclusion
- Patients undergo non-curative surgeries;
- Participants with skin allergy, skin ulceration and diabetes mellitus with poor glycemic control;
- Participants with severe dysfunction of heart, liver and kidney, who could not receive TCM treatment;
- Women who are pregnant or breastfeeding;
- Participants have mental illness or have difficulty in language communication and are unable to complete the study;
- Participants could not cooperate with this researcher for other reasons.
Key Trial Info
Start Date :
September 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 20 2023
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT04749381
Start Date
September 28 2020
End Date
February 20 2023
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100142